✦ LIBER ✦

741 INCIDENCE, PATHOLOGY AND MANAGEMENT OF INTRALUMINAL THROMBUS AT POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION

✍ Scribed by Johnston, Paul H.; Beck, Stephen D.W.; Cheng, Liang; Kesler, Ken; Bihrle, Richard; Foster, Richard S.

Book ID: 118485515
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 47 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.02.827

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence, Histology and Management of I

Incidence, Histology and Management of Intraluminal Thrombus at Post-Chemotherapy Retroperitoneal Lymph Node Dissection

✍ Johnston, Paul; Beck, Stephen D.W.; Cheng, Liang; Masterson, Timothy A.; Bihrle, 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 143 KB

664 OUTCOME OF VIABLE SEMINOMA AT POSTCH

664 OUTCOME OF VIABLE SEMINOMA AT POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION

✍ Rice, Kevin; Beck, Stephen; Bihrle, Richard; Lawrence, Einhorn; Foster, Richard 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB

Delayed Orchiectomy at Postchemotherapy

Delayed Orchiectomy at Postchemotherapy Retroperitoneal Lymph Node Dissection Due to Laterality of Retroperitoneal Metastatic Pattern Consistent with Testicular Primary: Assessment of Pathologic Findings

✍ James A. Brown; Richard Bihrle; Richard S. Foster 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Clinical and Pathological Features Predi

Clinical and Pathological Features Predictive of Nephrectomy at Post-Chemotherapy Retroperitoneal Lymph Node Dissection

✍ Cary, K. Clint; Beck, Stephen D.W.; Bihrle, Richard; Foster, Richard S. 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 453 KB

Viable germ cell tumor at postchemothera

Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection : Can we predict patients at risk of disease progression?

✍ Philippe E. Spiess; Nizar M. Tannir; Shi-Ming Tu; Gordon A. Brown; Ping Liu; Ash 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract ## BACKGROUND. Patients with viable tumor at time of postchemotherapy retroperitoneal lymph node dissection (PC‐RPLND) are at an increased risk of disease progression. The objective of the current study was to determine the clinical variables that predict this adverse outcome. ## METH

833 PATHOLOGY AT POST CHEMOTHERAPY RETRO

833 PATHOLOGY AT POST CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PCRPLND) IN PATIENTS WITH CHORIOCARCINOMA SYNDROME OR PURE CHORIOCARCINOMA OF THE TESTIS

✍ Risk, Michael; Beck, Stephen D.W.; Bihrle, Richard; Foster, Richard S. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 41 KB